Eli Lilly and Company (LLY)

Index:

S&P 100

$ 1,008.59
   
  • Change Today:
    $-9.38
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 944.80m
  • Volume: 1,452,748
  • Market Cap: $952,916m
  • RiskGrade: 179

LLY Overview

Founded in 1876, Eli Lilly is now a leading company involved in the discovery, development, manufacture and sale of pharmaceutical products. Headquartered in Indianapolis, the group's extensive portfolio of pharmaceutical products encompasses numerous areas, including neuroscience, endocrinology, oncology, animal health and other products for livestock and poultry, cardiovascular and anti-infectives. The company employs more than 43,000 people worldwide and sells its products in approximately 140 countries.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.6%
Div Cover 3.7
Op Mrgn 39.5%
ROCE 45.4%
Latest F'cast
P/E 45.7
PEG 0.5
Pr/Revenue 15.2
Pr/Book 37.5
Latest F'cast
Revenue 44.7%
PBT 102.9%
EPS 95.6%
DPS 15.4%

LLY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 28,318.40 6,155.50 615.00¢ 44.9 n/a -10% 353.00¢ 1.3%
31-Dec-22 28,541.40 6,806.40 693.00¢ 52.8 4.1 +13% 407.00¢ 1.1%
31-Dec-23 34,124.10 6,554.60 582.00¢ 100.2 n/a -16% n/a 0.0%
31-Dec-24 45,043.00 12,680.00 1,176.00¢ 65.6 0.6 +102% 540.00¢ 0.7%
31-Dec-25 65,179.00 25,731.00 2,300.00¢ 46.7 0.5 +96% 623.00¢ 0.6%

LLY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 82,073.30 38,466.25 3,461.23¢ 29.4 n/a n/a 675.60¢ 0.0%
31-Dec-27 95,322.58 45,807.91 4,225.40¢ 24.1 1.1 +22% 769.25¢ 0.0%
31-Dec-28 107,612.98 53,212.63 4,929.73¢ 20.6 1.2 +17% 843.11¢ 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

LLY ShareCast News

Novo Nordisk slashes US prices for Wegovy, Ozemp... 24-Feb-2026 ShareCast
Eli Lilly launches new Zepbound pen with month o... 23-Feb-2026 ShareCast
Eli Lilly issues upbeat guidance for 2026 amid s... 04-Feb-2026 ShareCast

LLY Top Newspaper Links

Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times
Botox maker to pay $600M to resolve federal inve... 02-Sep-2010 USA Today
Eli Lilly posts 3rd-quarter profit but analysts ... 22-Oct-2009 Chicago Tribune

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

LLY Market Data

Currency US Dollars
Share Price $ 1,008.59
Change Today $ -9.38
% Change -0.92 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 1,452,748
Shares Issued 944.80m
Market Cap $952,916m
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-Mar-2026

Time Volume / Share Price
14:38 40 @ $1,008.59
14:38 40 @ $1,008.59
14:38 40 @ $1,008.59
14:38 100 @ $1,009.05
14:38 40 @ $1,009.08

Top of Page